Previous close | 2.7100 |
Open | 2.7200 |
Bid | 2.6700 x 2400 |
Ask | 2.7200 x 2400 |
Day's range | 2.6600 - 2.7399 |
52-week range | 2.6600 - 8.0500 |
Volume | |
Avg. volume | 1,583,580 |
Market cap | 791.005M |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, although...
It's been a good week for AbCellera Biologics Inc. ( NASDAQ:ABCL ) shareholders, because the company has just released...
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript May 7, 2024 AbCellera Biologics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to AbCellera’s Q1, 2024 Business Update Conference Call. My name is Harry and […]